Natco Pharma Limited announced that the designation of Mr. M. Adinarayana, Compliance Officer has been redesignated as Company Secretary & Vice President (Legal & Corporate Affairs).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,000 INR | +0.27% | -1.95% | +23.29% |
05-28 | INDIA STOCKS-Metal, pharma stocks drive Indian benchmarks higher | RE |
05-28 | Transcript : NATCO Pharma Limited, Q4 2024 Earnings Call, May 28, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.29% | 2.14B | |
+43.01% | 739B | |
+32.34% | 598B | |
-5.89% | 353B | |
+17.25% | 318B | |
+3.50% | 285B | |
+16.47% | 240B | |
+9.26% | 210B | |
-5.07% | 206B | |
+6.13% | 164B |
- Stock Market
- Equities
- NATCOPHARM Stock
- News NATCO Pharma Limited
- Natco Pharma Limited Announces Redesignation of M. Adinarayana as Company Secretary & Vice President (Legal & Corporate Affairs)